All Stories

  1. Upfront lipid-lowering combination therapy in high cardiovascular risk patients: a route to effective atherosclerotic cardiovascular disease prevention

    Article • Cardiovascular Research, March 2025, Oxford University Press (OUP)

    Professor Peter E. Penson

  2. Correction to “Impact of surrogates for insulin resistance on mortality and life expectancy in primary care: a nationwide cross-sectional study with registry linkage (LIPIDOGRAM2015)” [The Lancet Regional Health – Europe 49 (2025) 101182]

    Article • The Lancet Regional Health - Europe, March 2025, Elsevier

    Professor Peter E. Penson

  3. Impact of Lipid-Lowering Combination Therapy With Statins and Ezetimibe vs Statin Monotherapy on the Reduction of Cardiovascular Outcomes: A Meta-analysis

    Article • Mayo Clinic Proceedings, March 2025, Elsevier

    Professor Peter E. Penson

  4. Impact of surrogates for insulin resistance on mortality and life expectancy in primary care: a nationwide cross-sectional study with registry linkage (LIPIDOGRAM2015)

    Article • The Lancet Regional Health - Europe, February 2025, Elsevier

    Professor Peter E. Penson

  5. Standardising lipid testing and reporting in the United Kingdom; a joint statement by HEART UK and The Association for Laboratory Medicine

    Article • Annals of Clinical Biochemistry International Journal of Laboratory Medicine, January 2025, SAGE Publications

    Professor Peter E. Penson

  6. Abstract 4136758: Apabetalone: evaluating cardiovascular and safety outcomes in meta-analysis

    Article • Circulation, November 2024, Wolters Kluwer Health

    Professor Peter E. Penson

  7. Reaping the rewards of a simplified dosing regimen

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, November 2024, Oxford University Press (OUP)

    Professor Peter E. Penson

  8. 2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)

    Article • Drugs, November 2024, Springer Science + Business Media

    Professor Peter E. Penson

  9. The upfront lipid-lowering combination therapy of statins and ezetimibe vs statin monotherapy in the reduction of cardiovascular outcomes. A meta-analysis.

    Article • European Heart Journal, October 2024, Oxford University Press (OUP)

    Professor Peter E. Penson

  10. Advancements in curcumin-loaded PLGA nanoparticle delivery systems: progressive strategies in cancer therapy

    Article • Journal of Drug Targeting, August 2024, Taylor & Francis

    Professor Peter E. Penson

  11. Risk of adverse cardiovascular events based on common genetic variants in 8-year follow-up of the LIPIDOGEN2015 population using the polygenic risk score (PRS) - study design and methodology.

    Article • Archives of Medical Science, August 2024, Termedia Sp. z.o.o.

    Professor Peter E. Penson

  12. 2024 Update on Postmarketing Nutrivigilance Safety Profile: A Line of Dietary Food Supplements Containing Red Yeast Rice for Dyslipidemia.

    Article • Archives of Medical Science, June 2024, Termedia Sp. z.o.o.

    Professor Peter E. Penson

  13. Patient experiences of their current asthma care and their views toward providing support for patients with asthma in community pharmacy: A Qualitative study

    Article • Exploratory Research in Clinical and Social Pharmacy, June 2024, Elsevier

    Professor Peter E. Penson

  14. 163 Prediction of outcomes in patients with hypertension using clinical laboratory biomarkers - a real-world analysis using a global federated database

    Article • May 2024, BMJ

    Professor Peter E. Penson

  15. Could siRNA therapeutics change the way we treat dyslipidemia?

    Article • Expert Opinion on Biological Therapy, May 2024, Taylor & Francis

    Professor Peter E. Penson

  16. Using read-across to build physiologically-based kinetic models: Part 1. Development of a KNIME workflow to assist analogue selection for PBK modelling

    Article • Computational Toxicology, March 2024, Elsevier

    Professor Peter E. Penson

  17. Using Read-Across to build Physiologically-Based Kinetic models: Part 2. Case studies for atenolol and flumioxazin

    Article • Computational Toxicology, March 2024, Elsevier

    Professor Peter E. Penson

  18. 4CPS-075 A systematic review of the target pharmacokinetic/pharmacodynamic parameters of antibiotics treating gram-negative infections

    Article • March 2024, BMJ

    Professor Peter E. Penson

  19. Evaluation of Urolithin A Efficacy in Heart Failure Patients with Reduced Ejection Fraction: A Randomized, Double-blind, Crossover, Placebo-controlled Clinical Trial

    Article • Reviews on Recent Clinical Trials, February 2024, Bentham Science Publishers

    Professor Peter E. Penson

  20. Adherence to the Atrial fibrillation Better Care pathway and the risk of adverse health outcomes in older care home residents with atrial fibrillation: a retrospective data linkage study 2003–18

    Article • Age and Ageing, February 2024, Oxford University Press (OUP)

    Professor Peter E. Penson

  21. Supermarket/Hypermarket Opportunistic Screening for Atrial Fibrillation (SHOPS-AF) using sensors embedded in the handles of supermarket trolleys: A feasibility study.

    Article • American Heart Journal, February 2024, Elsevier

    Professor Peter E. Penson

  22. Pharmacist-led intervention for older people with atrial fibrillation in long-term care (PIVOTALL study): a randomised pilot and feasibility study

    Article • BMC Geriatrics, January 2024, Springer Science + Business Media

    Professor Peter E. Penson

  23. Managing older people with atrial fibrillation and preventing stroke: a review of anticoagulation approaches

    Article • Expert Review of Cardiovascular Therapy, December 2023, Taylor & Francis

    Professor Peter E. Penson

  24. Pharmacokinetics and pharmacodynamics of direct oral anticoagulants

    Article • Expert Opinion on Drug Metabolism & Toxicology, November 2023, Taylor & Francis

    Professor Peter E. Penson

  25. S12 | Finding synergies for 3Rs – toxicokinetics, physiologically-based kinetic (PBK) models and read-across

    Article • Toxicology Letters, September 2023, Elsevier

    Professor Peter E. Penson

  26. The association between daily step count and all-cause and cardiovascular mortality: a meta-analysis

    Article • European Journal of Preventive Cardiology, August 2023, Oxford University Press (OUP)

    Professor Peter E. Penson

  27. Therapeutic drug monitoring: applying the ‘Goldilocks Principle’ to clinical pharmacology

    Article • Expert Review of Clinical Pharmacology, July 2023, Taylor & Francis

    Professor Peter E. Penson

  28. The role of nutraceuticals in heart failure muscle wasting as a result of inflammatory activity. The International Lipid Expert Panel (ILEP) Position Paper.

    Article • Archives of Medical Science, June 2023, Termedia Sp. z.o.o.

    Professor Peter E. Penson

  29. Metabolic syndrome is associated with similar long-term prognosis in non-obese and obese patients. An analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 cohort studies

    Article • European Journal of Preventive Cardiology, April 2023, Oxford University Press (OUP)

    Professor Peter E. Penson

  30. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

    Article • Pharmacological Research, March 2023, Elsevier

    Professor Peter E. Penson, Dr Sonu Bhaskar, Professor Erkin Mirrakhimov, Prof. Maciej Banach

  31. Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)

    Article • Progress in Cardiovascular Diseases, March 2023, Elsevier

    Professor Peter E. Penson

  32. Which Statin is Best for the Kidneys?

    Article • Current Vascular Pharmacology, January 2023, Bentham Science Publishers

    Professor Peter E. Penson, Prof. Maciej Banach

  33. Statin Intolerance: An Overview for Clinicians

    Article • January 2023, Springer Science + Business Media

    Professor Peter E. Penson

  34. Do antihypertensive medicines increase the risk of depression?

    Article • The Pharmaceutical Journal, January 2023, Royal Pharmaceutical Society (Pharmaceutical Press)

    Professor Peter E. Penson

  35. 1208 FEASIBILITY OF A PHARMACIST-LED INTERVENTION FOR ATRIAL FIBRILLATION IN LONG-TERM CARE: THE PIVOTALL STUDY

    Article • Age and Ageing, January 2023, Oxford University Press (OUP)

    Professor Peter E. Penson

  36. Abstracts of the 18th Congress of the European Geriatric Medicine Society

    Article • European Geriatric Medicine, December 2022, Springer Science + Business Media

    Professor Peter E. Penson

  37. Prevalence and outcomes of atrial fibrillation in older people living in care homes in Wales: a routine data linkage study 2003–2018

    Article • Age and Ageing, December 2022, Oxford University Press (OUP)

    Professor Peter E. Penson

  38. Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022)

    Article • Cardiovascular Diabetology, November 2022, Springer Science + Business Media

    Professor Peter E. Penson

  39. Anticoagulation in older people with atrial fibrillation moving to care homes: a data linkage study

    Article • British Journal of General Practice, November 2022, Royal College of General Practitioners

    Professor Peter E. Penson

  40. 2022: The Year in Cardiovascular Disease – The Year of Upfront Lipid Lowering Combination Therapy.

    Article • Archives of Medical Science, October 2022, Termedia Sp. z.o.o.

    Professor Peter E. Penson

  41. Adherence to statin therapy - it seems we know everything, yet we do nothing…

    Article • European Heart Journal Open, October 2022, Oxford University Press (OUP)

    Professor Peter E. Penson

  42. Individualized therapy in statin intolerance: the key to success

    Article • European Heart Journal, October 2022, Oxford University Press (OUP)

    Professor Peter E. Penson

  43. Factors associated with prescription of oral anticoagulation for atrial fibrillation in older people living in care homes in Wales: a routine data linkage study 2003–2018

    Article • European Heart Journal, October 2022, Oxford University Press (OUP)

    Professor Peter E. Penson

  44. Prevalence and outcomes of atrial fibrillation in older people living in care homes in Wales: a routine data linkage study 2003–2018

    Article • European Heart Journal, October 2022, Oxford University Press (OUP)

    Professor Peter E. Penson

  45. Selected Abstracts from Pharmacology 2022

    Article • British Journal of Clinical Pharmacology, September 2022, Wiley

    Professor Peter E. Penson

  46. Risk factors for post sternotomy wound complications across the patient journey: A systematised review of the literature

    Article • Heart & Lung, September 2022, Elsevier

    Professor Peter E. Penson

  47. Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A position paper of the International Lipid Expert Panel

    Article • Pharmacological Research, September 2022, Elsevier

    Professor Peter E. Penson

  48. P17-04 An automated tool for selection of chemical analogues to facilitate development of new physiologically-based kinetic models using a read-across approach

    Article • Toxicology Letters, September 2022, Elsevier

    Professor Peter E. Penson

  49. Integrated care for atrial fibrillation management: The role of the pharmacist

    Article • The American Journal of Medicine, August 2022, Elsevier

    Professor Peter E. Penson

  50. 1300 Transfer of outpatient paediatric prescriptions to primary care via the Electronic Prescription Service (EPS)- community pharmacist views

    Article • August 2022, BMJ

    Professor Peter E. Penson

  51. Identifying and addressing pill aversion in adults without physiological‐related dysphagia: A narrative review

    Article • British Journal of Clinical Pharmacology, July 2022, Wiley

    Professor Peter E. Penson

  52. Curcumin - The Nutraceutical With Pleiotropic Effects? Which Cardiometabolic Subjects Might Benefit the Most?

    Article • Frontiers in Nutrition, May 2022, Frontiers

    Professor Peter E. Penson

  53. Supermarket/Hypermarket Opportunistic Screening for Atrial Fibrillation (SHOPS-AF): A Mixed Methods Feasibility Study Protocol

    Article • Journal of Personalized Medicine, April 2022, MDPI AG

    Lis Neubeck, Professor Peter E. Penson

  54. Lifetime serum concentration of 25-hydroxyvitamin D 25(OH) is associated with hand grip strengths: insight from a Mendelian randomisation

    Article • Age and Ageing, April 2022, Oxford University Press (OUP)

    Professor Peter E. Penson

  55. Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)

    Article • Journal of Cachexia Sarcopenia and Muscle, March 2022, Wiley

    Professor Peter E. Penson, Dr Sonu Bhaskar, Professor Erkin Mirrakhimov

  56. Prevalence of statin intolerance: a meta-analysis

    Article • European Heart Journal, February 2022, Oxford University Press (OUP)

    Professor Peter E. Penson

  57. Homozygous familial hypercholesterolaemia: shedding new light on a rare but deadly condition

    Article • European Journal of Preventive Cardiology, February 2022, Oxford University Press (OUP)

    Professor Peter E. Penson, Prof. Maciej Banach

  58. Warfarin—Is Self-Care the Best Care?

    Article • Thrombosis and Haemostasis, February 2022, Thieme Publishing Group

    Professor Peter E. Penson

  59. Relationship Between Anti-DFS70 Autoantibodies and Oxidative Stress

    Article • Biomarker Insights, January 2022, SAGE Publications

    Professor Peter E. Penson

  60. Stop and Go: Barriers and Facilitators to Care Home Research

    Article • Journal of Frailty & Aging, January 2022, SERDI

    Professor Peter E. Penson

  61. Long-COVID-19: Definition, Epidemiology, and Clinical Implications

    Article • January 2022, Springer Science + Business Media

    Professor Peter E. Penson

  62. CRISPR Gene Editing in Lipid Disorders and Atherosclerosis: Mechanisms and Opportunities

    Article • Metabolites, December 2021, MDPI AG

    Professor Peter E. Penson

  63. Potential Benefits of Phytochemicals for Abdominal Aortic Aneurysm

    Article • Current Medicinal Chemistry, December 2021, Bentham Science Publishers

    Professor Peter E. Penson

  64. The Differences in the Prevalence of Cardiovascular Disease, Its Risk Factors, and Achievement of Therapeutic Goals among Urban and Rural Primary Care Patients in Poland: Results from the LIPIDOGRAM 2015 Study

    Article • Journal of Clinical Medicine, November 2021, MDPI AG

    Professor Peter E. Penson

  65. A Systematic Review of Published Physiologically based Kinetic Models and an Assessment of their Chemical Space Coverage

    Article • Alternatives to Laboratory Animals, November 2021, SAGE Publications

    Professor Peter E. Penson

  66. Extreme cardiovascular risk—do we need a new risk category?

    Article • European Heart Journal, November 2021, Oxford University Press (OUP)

    Professor Peter E. Penson, Prof. Maciej Banach

  67. Analysis of the impact of sex and age on the variation in the prevalence of antinuclear autoantibodies in Polish population: a nationwide observational, cross-sectional study

    Article • Rheumatology International, November 2021, Springer Science + Business Media

    Professor Peter E. Penson, Prof. Maciej Banach

  68. The management of asthma in adult patients in the community pharmacy setting: Literature review

    Article • Research in Social and Administrative Pharmacy, November 2021, Elsevier

    Professor Peter E. Penson

  69. Associations between serum triglycerides and abdominal aortic calcification in a cross-sectional study from the United States of America

    Article • European Heart Journal, October 2021, Oxford University Press (OUP)

    Professor Peter E. Penson

  70. Association between ankle-brachial index and cardiovascular mortality in a cohort from the United States of America

    Article • European Heart Journal, October 2021, Oxford University Press (OUP)

    Professor Peter E. Penson

  71. The prevalence of statin intolerance worldwide: a systematic review and meta-analysis with 4,143,517 patients

    Article • European Heart Journal, October 2021, Oxford University Press (OUP)

    Professor Peter E. Penson

  72. Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 Study

    Article • Journal of Clinical Medicine, September 2021, MDPI AG

    Professor Peter E. Penson, Prof. Maciej Banach

  73. Clinical Features of Familial Hypercholesterolemia in Children and Adults in EAS-FHSC Regional Center for Rare Diseases in Poland

    Article • Journal of Clinical Medicine, September 2021, MDPI AG

    Professor Peter E. Penson, Prof. Maciej Banach

  74. Challenges and Opportunities on Lipid Metabolism Disorders Diagnosis and Therapy: Novel Insights and Future Perspective

    Article • Metabolites, September 2021, MDPI AG

    Professor Peter E. Penson

  75. Efficacy and safety of colchicine in patients with coronary artery disease: A systematic review and meta‐analysis of randomized controlled trials

    Article • British Journal of Clinical Pharmacology, September 2021, Wiley

    Professor Peter E. Penson

  76. RNA Silencing in the Management of Dyslipidemias

    Article • Current Atherosclerosis Reports, September 2021, Springer Science + Business Media

    Professor Peter E. Penson

  77. Bacterial lipopolysaccharide–Stoking the fire of residual risk?

    Article • Trends in Cardiovascular Medicine, September 2021, Elsevier

    Professor Peter E. Penson

  78. Risk-factors associated with extremely high cardiovascular risk of mid- and long-term mortality following myocardial infarction: Analysis of the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTer (TERCET) registry

    Article • Atherosclerosis, September 2021, Elsevier

    Professor Peter E. Penson, Prof. Maciej Banach

  79. The interaction of Helicobacter pylori with cancer immunomodulatory stromal cells: New insight into gastric cancer pathogenesis

    Article • Seminars in Cancer Biology, September 2021, Elsevier

    Professor Peter E. Penson, Prof. Maciej Banach

  80. Nutraceuticals for the Control of Dyslipidaemias in Clinical Practice

    Article • Nutrients, August 2021, MDPI AG

    Prof. Maciej Banach, Professor Peter E. Penson

  81. Statins as anti-pyroptotic agents

    Article • Archives of Medical Science, August 2021, Termedia Sp. z.o.o.

    Professor Peter E. Penson

  82. Postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemia

    Article • Archives of Medical Science, July 2021, Termedia Sp. z.o.o.

    Professor Peter E. Penson

  83. Serum antinuclear autoantibodies are associated with measures of oxidative stress and lifestyle factors - analysis of LIPIDOGRAM2015 and LIPIDOGEN2015 studies.

    Article • Archives of Medical Science, July 2021, Termedia Sp. z.o.o.

    Professor Peter E. Penson, Prof. Maciej Banach

  84. Nocebo/drucebo effect in statin-intolerant patients: an attempt at recommendations

    Article • European Heart Journal, June 2021, Oxford University Press (OUP)

    Professor Peter E. Penson, Prof. Maciej Banach

  85. Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP)

    Article • Progress in Cardiovascular Diseases, June 2021, Elsevier

    Dr Sonu Bhaskar, Professor Peter E. Penson, Professor Erkin Mirrakhimov

  86. Assessment of asthma management in adult patients: A retrospective case-note review in a general practice

    Article • British Journal of Pharmacy, May 2021, University of Huddersfield Press

    Professor Peter E. Penson

  87. Colchicine and Cardiovascular Outcomes: a Critical Appraisal of Recent Studies

    Article • Current Atherosclerosis Reports, May 2021, Springer Science + Business Media

    Professor Peter E. Penson

  88. Exploring pharmacists’ views surrounding conscientious objection to abortion and implications in practice

    Article • International Journal of Pharmacy Practice, April 2021, Oxford University Press (OUP)

    Professor Peter E. Penson

  89. Prevalence of anti-nuclear autoantibodies (ANA) in the general Polish population - analysis of the influence of sex and age on the variability of ANA.

    Article • April 2021, Research Square

    Professor Peter E. Penson

  90. Effects of statins on myocarditis: A review of underlying molecular mechanisms

    Article • Progress in Cardiovascular Diseases, February 2021, Elsevier

    Professor Peter E. Penson

  91. OPTIMAL USE OF LIPID-LOWERING THERAPY AFTER ACUTE CORONARY SYNDROMES: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)

    Article • Pharmacological Research, February 2021, Elsevier

    Professor Peter E. Penson

  92. Drucebo effect – the challenge we should all definitely face!

    Article • Archives of Medical Science, January 2021, Termedia Sp. z.o.o.

    Professor Peter E. Penson, Prof. Maciej Banach

  93. Lipid-lowering therapies: Better together

    Article • Atherosclerosis, January 2021, Elsevier

    Professor Peter E. Penson, Prof. Maciej Banach

  94. OUP accepted manuscript

    Article • European Journal of Preventive Cardiology, January 2021, Oxford University Press (OUP)

    Professor Peter E. Penson

  95. Recent advancements in liposome-based strategies for effective drug delivery to the brain

    Article • Current Medicinal Chemistry, December 2020, Bentham Science Publishers

    Professor Peter E. Penson

  96. Management of Statin Intolerance

    Article • December 2020, Springer Science + Business Media

    Professor Peter E. Penson

  97. Statins, COVID-19, and coronary artery disease: killing two birds with one stone

    Article • Metabolism, December 2020, Elsevier

    Professor Peter E. Penson

  98. How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors

    Article • Progress in Cardiovascular Diseases, December 2020, Elsevier

    Professor Peter E. Penson

  99. Statins and LDL-C in Secondary Prevention—So Much Progress, So Far to Go

    Article • JAMA Network Open, November 2020, American Medical Association (AMA)

    Professor Peter E. Penson

  100. Natural compounds as anti-atherogenic agents: Clinical evidence for improved cardiovascular outcomes

    Article • Atherosclerosis, November 2020, Elsevier

    Professor Peter E. Penson

  101. Comparison of LDL-C calculation by friedewald and martin/hopkins methods in 12,243 adults from the United States of America

    Article • European Heart Journal, November 2020, Oxford University Press (OUP)

    Professor Peter E. Penson

  102. LDL-C: lower is better for longer—even at low risk

    Article • BMC Medicine, October 2020, Springer Science + Business Media

    Professor Peter E. Penson

  103. Pharmacist implementation of a treatment pathway for atrial fibrillation in care home residents

    Article • October 2020, Springer Science + Business Media

    Professor Peter E. Penson

  104. The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia

    Article • Current Atherosclerosis Reports, September 2020, Springer Science + Business Media

    Professor Peter E. Penson

  105. Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic

    Article • Pharmacological Research, August 2020, Elsevier

    Prof. Maciej Banach, Professor Peter E. Penson

  106. Efficacy and safety of bempedoic acid for the treatment of hypercholesterolemia: A systematic review and meta-analysis

    Article • PLoS Medicine, July 2020, PLOS

    Professor Peter E. Penson, Dr Arrigo FG CICERO, Prof. Maciej Banach, Professor Erkin Mirrakhimov

  107. Epigenetic control of atherosclerosis via DNA methylation: A new therapeutic target?

    Article • Life Sciences, July 2020, Elsevier

    Professor Peter E. Penson

  108. Vernakalant hydrochloride for the treatment of atrial fibrillation: evaluation of its place in clinical practice

    Article • Future Cardiology, May 2020, Future Medicine

    Professor Peter E. Penson

  109. What's new in lipid‐lowering pharmacology? Integrating basic and clinical research to improve patient outcomes

    Article • British Journal of Clinical Pharmacology, May 2020, Wiley

    Professor Peter E. Penson

  110. Statin therapy in athletes and patients performing regular intense exercise – Position paper from the International Lipid Expert Panel (ILEP)

    Article • Pharmacological Research, May 2020, Elsevier

    Professor Peter E. Penson, Professor Erkin Mirrakhimov

  111. What do we know about the role of lipoprotein(a) in atherogenesis 57 years after its discovery?

    Article • Progress in Cardiovascular Diseases, May 2020, Elsevier

    Professor Peter E. Penson

  112. The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP)

    Article • Clinical Nutrition, May 2020, Elsevier

    Professor Peter E. Penson, Professor Erkin Mirrakhimov

  113. Liposome Circulation Time is Prolonged by CD47 Coating

    Article • Protein and Peptide Letters, April 2020, Bentham Science Publishers

    Professor Peter E. Penson

  114. Intake of Caffeine and Its Association with Physical and Mental Health Status among University Students in Bahrain

    Article • Foods, April 2020, MDPI AG

    Professor Peter E. Penson

  115. Association of types of dietary fats and all-cause and cause-specific mortality: A prospective cohort study and meta-analysis of prospective studies with 1,164,029 participants

    Article • Clinical Nutrition, April 2020, Elsevier

    Professor Peter E. Penson

  116. Application of PLGA nano/microparticle delivery systems for immunomodulation and prevention of allotransplant rejection

    Article • Expert Opinion on Drug Delivery, March 2020, Taylor & Francis

    Professor Peter E. Penson

  117. Vitamin D and SAMS

    Article • January 2020, Springer Science + Business Media

    Professor Peter E. Penson

  118. Inclisiran—New hope in the management of lipid disorders?

    Article • Journal of Clinical Lipidology, January 2020, Elsevier

    Professor Peter E. Penson

  119. Statin-Induced Nitric Oxide Signaling: Mechanisms and Therapeutic Implications

    Article • Journal of Clinical Medicine, November 2019, MDPI AG

    Professor Peter E. Penson

  120. Statins and Lp(a): do not make perfect the enemy of excellent

    Article • European Heart Journal, November 2019, Oxford University Press (OUP)

    Professor Peter E. Penson, Prof. Maciej Banach

  121. The Role of Protein SUMOylation in the Pathogenesis of Atherosclerosis

    Article • Journal of Clinical Medicine, November 2019, MDPI AG

    Professor Peter E. Penson

  122. P705Step by step diagnosis and management of statin intolerance: position paper from an international lipid expert panel

    Article • European Heart Journal, October 2019, Oxford University Press (OUP)

    Professor Peter E. Penson

  123. Warfarin Therapy and Improved Anticoagulation Control by Patient Self-Management

    Article • Thrombosis and Haemostasis, September 2019, Thieme Publishing Group

    Professor Peter E. Penson

  124. A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposome

    Article • Drug Discovery Today, September 2019, Elsevier

    Professor Peter E. Penson, Prof. Maciej Banach

  125. Regulatory T cells: possible mediators for the anti-inflammatory action of statins

    Article • Pharmacological Research, September 2019, Elsevier

    Professor Peter E. Penson

  126. Genetic testing in familial hypercholesterolaemia: What does it add?

    Article • European Journal of Preventive Cardiology, August 2019, SAGE Publications

    Prof. Maciej Banach, Professor Peter E. Penson

  127. Poster Abstracts

    Article • International Journal of Pharmacy Practice, April 2019, Wiley

    Professor Peter E. Penson

  128. Worldwide Dyslipidemia Guidelines

    Article • Current Cardiovascular Risk Reports, January 2019, Springer Science + Business Media

    Professor Peter E. Penson

  129. What have we learned about lipids and cardiovascular risk from PCSK9 inhibitor outcomes trials?

    Article • Cardiovascular Research, January 2019, Oxford University Press (OUP)

    Prof. Maciej Banach, Professor Peter E. Penson

  130. Associations between the lipid profile and the development of hypertension in young individuals – the preliminary study

    Article • Archives of Medical Science, January 2019, Termedia Sp. z.o.o.

    Professor Peter E. Penson

  131. Effects of carbohydrate-restricted diets on low-density lipoprotein cholesterol levels in overweight and obese adults: a systematic review and meta-analysis

    Article • Nutrition Reviews, December 2018, Oxford University Press (OUP)

    Professor Peter E. Penson

  132. Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin-associated muscle symptoms, under blinded and open-label conditions

    Article • Journal of Cachexia Sarcopenia and Muscle, October 2018, Wiley

    Prof. Maciej Banach, Professor Peter E. Penson

  133. Embracing the polypill as a cardiovascular therapeutic: is this the best strategy?

    Article • Expert Opinion on Pharmacotherapy, October 2018, Taylor & Francis

    Prof. Maciej Banach, Professor Maciej Banach, Professor Peter E. Penson

  134. Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study

    Article • European Heart Journal, August 2018, Oxford University Press (OUP)

    Professor Peter E. Penson, Prof. Maciej Banach

  135. Associations between cardiovascular disease, cancer, and very low high-density lipoprotein cholesterol in the REasons for Geographical and Racial Differences in Stroke (REGARDS) study

    Article • Cardiovascular Research, August 2018, Oxford University Press (OUP)

    Professor Peter E. Penson, Prof. Maciej Banach

  136. P3836The prognostic accuracy of bleeding risk prediction scores in patients with atrial fibrillation: a systematic review and meta-analysis

    Article • European Heart Journal, August 2018, Oxford University Press (OUP)

    Professor Peter E. Penson

  137. P5086Associations between very low concentrations of LDL-Cholesterol, hsCRP and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study

    Article • European Heart Journal, August 2018, Oxford University Press (OUP)

    Professor Peter E. Penson

  138. Lipoprotein(a) and the risk of atrial fibrillation – is there a link

    Article • Heart Beat Journal, December 2017, Fundacja Heart Beat

    Professor Peter E. Penson

  139. The effects of cinnamon supplementation on blood lipid concentrations: A systematic review and meta-analysis

    Article • Journal of Clinical Lipidology, November 2017, Elsevier

    Prof. Maciej Banach, Professor Peter E. Penson

  140. The sirtuin family members SIRT1, SIRT3 and SIRT6: Their role in vascular biology and atherogenesis

    Article • Atherosclerosis, October 2017, Elsevier

    Prof. Maciej Banach, Professor Peter E. Penson

  141. Autonomic and Autacoid Pharmacology: Goodbye and thank you

    Article • Autonomic and Autacoid Pharmacology, September 2017, Wiley

    Professor Peter E. Penson

  142. Does coffee consumption alter plasma lipoprotein(a) concentrations? A systematic review

    Article • Critical Reviews in Food Science and Nutrition, August 2017, Taylor & Francis

    Prof. Maciej Banach, Professor Peter E. Penson

  143. The effect of statins on cardiovascular outcomes by smoking status: A systematic review and meta-analysis of randomized controlled trials

    Article • Pharmacological Research, August 2017, Elsevier

    Prof. Maciej Banach, Professor Peter E. Penson

  144. 3100Effects of morning versus evening statin therapy on lipid profile: a systematic review and meta-analysis

    Article • European Heart Journal, August 2017, Oxford University Press (OUP)

    Professor Peter E. Penson

  145. 3104Associations between cardiovascular disease, cancer and very low hdl cholesterol in the reasons for geographical and racial differences in stroke (REGARDS) study

    Article • European Heart Journal, August 2017, Oxford University Press (OUP)

    Professor Peter E. Penson

  146. P627Associations between very low concentrations of LDL-cholesterol and health outcomes in the reasons for geographical and racial differences in stroke (REGARDS) Study

    Article • European Heart Journal, August 2017, Oxford University Press (OUP)

    Professor Peter E. Penson

  147. Effects of morning vs evening statin administration on lipid profile: A systematic review and meta-analysis

    Article • Journal of Clinical Lipidology, July 2017, Elsevier

    Professor Peter E. Penson, Prof. Maciej Banach

  148. The Effects of Tamoxifen on Plasma Lipoprotein(a) Concentrations: Systematic Review and Meta-Analysis

    Article • Drugs, June 2017, Springer Science + Business Media

    Prof. Maciej Banach, Professor Peter E. Penson

  149. 220 Daphnia magna as a model for quantifying chaos in cardiac arrhythmia

    Article • Heart, June 2017, BMJ

    Professor Peter E. Penson

  150. Relationship between long noncoding RNAs and physiological risk factors of cardiovascular disease

    Article • Journal of Clinical Lipidology, May 2017, Elsevier

    Prof. Maciej Banach, Professor Peter E. Penson

  151. The role of nutraceuticals in the prevention of cardiovascular disease

    Article • Cardiovascular Diagnosis and Therapy, April 2017, AME Publishing Company

    Prof. Maciej Banach, Professor Peter E. Penson

  152. Evaluating bempedoic acid for the treatment of hyperlipidaemia

    Article • Expert Opinion on Investigational Drugs, January 2017, Taylor & Francis

    Prof. Maciej Banach, Professor Peter E. Penson

  153. Association between telomere length and complete blood count in US adults

    Article • Archives of Medical Science, January 2017, Termedia Sp. z.o.o.

    Prof. Maciej Banach, Professor Peter E. Penson

  154. D-003 (Saccharum officinarum): The forgotten lipid-lowering agent

    Article • Pharmacological Research, December 2016, Elsevier

    Prof. Maciej Banach, Professor Peter E. Penson

  155. Effects of pentoxifylline on inflammatory markers and blood pressure

    Article • Journal of Hypertension, December 2016, Wolters Kluwer Health

    Prof. Maciej Banach, Professor Peter E. Penson

  156. Sunday 28 August 2016

    Article • European Heart Journal, August 2016, European Society of Cardiology

    Professor Peter E. Penson

  157. Monday 29 August 2016

    Article • European Heart Journal, August 2016, European Society of Cardiology

    Professor Peter E. Penson

  158. Tuesday 30 August 2016

    Article • European Heart Journal, August 2016, European Society of Cardiology

    Professor Peter E. Penson, Asoc Prof MD PhD FESC Oliver Kalpak

  159. Bioresorbable scaffold — A magic bullet for the treatment of coronary artery disease?

    Article • International Journal of Cardiology, July 2016, Elsevier

    Prof. Maciej Banach, Professor Peter E. Penson

  160. Autonomic & Autacoid Pharmacology 2016: The year in review

    Article • Autonomic and Autacoid Pharmacology, July 2016, Wiley

    Professor Peter E. Penson

  161. Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases – Some answers and still many questions

    Article • Critical Reviews in Clinical Laboratory Sciences, June 2016, Taylor & Francis

    Prof. Maciej Banach, Professor Peter E. Penson

  162. Does vitamin D supplementation alter plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials

    Article • Pharmacological Research, May 2016, Elsevier

    Prof. Maciej Banach, Professor Peter E. Penson

  163. Autonomic & Autacoid Pharmacology: past, present and future

    Article • Autonomic and Autacoid Pharmacology, December 2015, Wiley

    Professor Peter E. Penson

  164. Developing skills to deliver alcohol screening and brief intervention (SBI) in community pharmacy

    Article • Addiction Science & Clinical Practice, September 2013, Springer Science + Business Media

    Professor Peter E. Penson

  165. Lecturing: A lost art

    Article • Currents in Pharmacy Teaching and Learning, January 2012, Elsevier

    Professor Peter E. Penson

  166. ChemInform Abstract: Synthesis of Antagonists of Muscarinic (M3) Receptors.

    Article • ChemInform, September 2011, Wiley

    Professor Peter E. Penson

  167. Synthesis of antagonists of muscarinic (M3) receptors

    Article • Collection of Czechoslovak Chemical Communications, January 2011, Institute of Organic Chemistry & Biochemistry

    Professor Peter E. Penson

  168. Incense – A problematic method of drug-delivery

    Article • Medical Hypotheses, April 2009, Elsevier

    Professor Peter E. Penson

  169. Activation of β-adrenoceptors mimics preconditioning of rat-isolated atria and ventricles against ischaemic contractile dysfunction

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, July 2008, Springer Science + Business Media

    Professor Emma J Kidd, Professor Peter E. Penson

  170. Protective role of β2- and β3-adrenoceptors at reperfusion in isolated rat heart

    Article • Journal of Molecular and Cellular Cardiology, April 2008, Elsevier

    Professor Peter E. Penson, Professor Emma J Kidd

  171. Vasopressors for cardiopulmonary resuscitation

    Article • Pharmacology & Therapeutics, July 2007, Elsevier

    Professor Peter E. Penson

  172. Effects of hypoxia on the vasodilator activity of nifedipine and evidence of secondary pharmacological properties

    Article • European Journal of Pharmacology, May 2006, Elsevier

    Professor Peter E. Penson

  173. The roles of alpha- and beta-adrenoceptor stimulation in myocardial ischaemia

    Article • Autonomic and Autacoid Pharmacology, October 2004, Wiley

    Professor Peter E. Penson